BIOCON
|
The Current P/B Ratio of BIOCON is 2.70.
| Share Price | ₹379.7 | Jan 09,2026 |
| Market Cap | ₹57,258.8 Cr | |
| Book Value | ₹21,219.1 Cr | Mar2025 - Consolidated Results |
| Price/Book | 2.70x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of BIOCON
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹57,258.8 Cr] as on Jan 09,2026
(/) Book Value [ ₹21,219.1 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 2.70x ]
Thus, for BIOCON , the investors are currently willing to pay '2.70 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of BIOCON !
The chart below summarizes the trend in P/B Ratio of BIOCON over the last five years.
Historical PB (Price/Book ) ratio chart of BIOCON
PB Ratio Performance Analysis for BIOCON
- BIOCON 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.28x.
- BIOCON 's operated at median p/b ratio of 1.93x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BIOCON 's p/b ratio peaked in Mar2021 at 6.57x.
- BIOCON 's p/b ratio hit its five-year low in Mar2023 of 1.41x.
How does BIOCON 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| BIOCON | 21,219.10 | 2.70 | 57,258.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.75 | 415,073.0 |
| DIVIS LABORATORIES LTD | 14,969.00 | 11.73 | 175,657.0 |
| CIPLA LTD | 31,079.30 | 3.81 | 118,431.0 |
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 17.67 | 134,121.0 |
| DR REDDYS LABORATORIES LTD | 33,404.90 | 3.02 | 100,944.0 |
| MANKIND PHARMA LTD | 14,288.70 | 6.36 | 90,806.8 |
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 3.76 | 90,052.9 |
| LUPIN LTD | 17,119.50 | 5.82 | 99,648.4 |
| AUROBINDO PHARMA LTD | 32,653.30 | 2.13 | 69,609.1 |
| ABBOTT INDIA LTD | 4,204.27 | 14.17 | 59,589.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs BIOCON 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.13x |
| Max industry PB | 17.67x |
| Median industry PB | 5.75x |
| Average industry PB | 6.99x |
You may also like the below Video Courses